Get started
DENALI THERADRNDENALI THERADRNDENALI THERADRN

DENALI THERADRN

No trades
See on Supercharts
Overview News
Ideas
Technicals

D2NL34 trade ideas

DNLI, Aroon Indicator entered an Uptrend on December 08, 2020.Over the last three days, Tickeron's A.I.dvisor has detected that DNLI's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call options in the next month. Tickeron's A.I.dvisor backtested this indicator and found 162 similar cases, 149 of which were successful. Based on this data, the odds of success are 90%. Current price $78.09 is above $43.65 the highest support line found by Tickeron A.I. Throughout the month of 11/05/20 - 12/08/20, the price experienced a +47% Uptrend. During the week of 12/01/20 - 12/08/20, the stock enjoyed a +23% Uptrend growth. Bullish Trend Analysis The Momentum Indicator moved above the 0 level on December 03, 2020. You may want to consider a long position or call options on DNLI as a result. Tickeron A.I. detected that in 37 of 42 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%. DNLI moved above its 50-day Moving Average on August 06, 2020 date and that indicates a change from a downward trend to an upward trend. The 10-day Moving Average for DNLI crossed bullishly above the 50-day moving average on August 10, 2020. This indicates that the trend has shifted higher and could be considered a buy signal. Tickeron A.I. detected that in 7 of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%. Following a +16.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNLI advanced for three days, in 152 of 170 cases, the price rose further within the following month. The odds of a continued upward trend are 89%. The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 149 of 162 cases where DNLI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
NASDAQ:DNLILong
by AlTorress
DNLI - getting ripe for a rebound soonDNLI appearing to be finding support at the 38% fibonacci retracement level (60.0-60.50). The selling volume has been diminishing and there is also a potential bullish divergence setting up between price anad stochastic. Looking to long at the break above 62.20 with initial stop @ 59.70. Near term target @ 72. Disclaimer: This is just my own analysis and opinion for discussion and is not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance. Thank you. Feel free to comment and join the discussion! :)
NASDAQ:DNLILong
by Juliac
DENALI THERAPEUTICS View Hello traders, DENALI THERAPEUTICS is in a historic moment we can witness a high point in its history. It is in a bullish momentum with a larger trace at the bottom than at the top and a large volume of sell at the beginning of the session. On the TIMEFRAME M1 we see the shape of a hammer bear candle and it is about to retest on the stabilization zone. Strong potential to break out the price then the stabilization zone just after to join another. And if the buying force is still present still breakout an area to go and test the symbolic figure of 64.00. Please LIKE & FOLLOW, thank you!
NASDAQ:DNLIShort
by stephanelibatd
DNLI - short term swing upDNLI pulled back into support zone 39-40 (horizontal & 50% fib retracement of the recent AB swing up) and started to stage a rebound last Thursday, followed by a retest of the support zone on Fri and again rebounded to close with a bullish dragonfly candlestick. This coupled with bullish divergence between price and RSI increased the odds of a sustainable bounce from here (with a stop loss just below the support zone @ 39). However! (risk disclaimer here) with presidential election and earnings round the corner, it might be prudent keep positions small or scale out at least partially before these events. Disclaimer: This is just my own analysis and opinion for discussion and is not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance. Thank you.
NASDAQ:DNLILong
by Juliac
2
Wall streets darling DNLI halts at key resistanceSince the pandemic March lows, Denali Therapeutics Inc (DNLI) has enjoyed a multi-month rally surpassing it’s January ‘20 highs with ease, amid a bout of increased buying activity following Q2 earnings. As well as individual investors, hedge funds are also optimistic about the future share price of DNLI. Official data shows the number of hedge fund bets increased to seven, meaning the bullish number of hedge funds currently holding positions in the security is at an all-time high. DNLI is currently trading at 41.56 at the time of writing, which is a key level of interest as it tests multi-month fib extension at (3) taken from the highs of January ‘20 at (1) and the lows of March this year at (2). Coupled with that a well-formed rising wedge pattern is in play whereby it’s resistance line junctions exactly at fib extension (3). A break above this dual resistance cluster would be considered all the more bullish, with a view to 45.00 as the next target to watch for. Any pullbacks around these current levels are expected to be shallow and short-lived, providing better buying opportunities for the midterm. Below wedge support throws this bullish outlook into question for the short to midterm.
NASDAQ:DNLI
by rapidrunners
The technicals in this biotech stock remind me of Tesla The major pattern above is an ascending broadening wedge just like the pattern in Tesla shown below. Notice Tesla broke out of a major multi year (5 year) consolidation and developed a minor pattern above the breakout. After the minor pattern, Tesla shot to 2k + before announcing their split. Here's the analysis I did on Tesla just after it developed a minor pattern above the ascending broadening wedge: Here is the zoomed in Daily chart of DNLI: This is a confirmed breakout on the smaller time-frame which gives the signal to get long.
NASDAQ:DNLILong
by Lanmar
6
Advance DNL151 into Late Stage Clinical Studies in Parkinson’sDenali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients DNL151 selected to advance into two late stage studies Denali and collaboration partner Biogen are finalizing DNL151 clinical development plans and intend to commence patient enrollment in 2021 Denali is currently completing further dose escalation cohorts in an expanded Phase 1 and an additional cohort in the Phase 1b study ---------------------------------------------------------- Biogen Inc. BIIB, announced a $465 million equity investment as part of a collaboration on Denali's treatment for Parkinson's disease. Biogen will make an upfront payment of $560 million, as well as the equity investment from the purchase of 13.3 million newly issued shares, representing about 11% of the shares outstanding, at $34.94 per share, which is 50% above Wednesday's closing price of $23.24. Denali will also be eligible to receive up to $1.125 billion in potential milestone payments depending on the achievement of certain development and commercial milestones. www.marketwatch.com finance.yahoo.com finance.yahoo.com
NASDAQ:DNLI
by AlenCiken